Черных Наталья Александровна

Черных Наталья Александровна

Auto-generated profile, based on publicly available information

Черных Наталья Александровна

Central Research Institute of Tuberculosis

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2022 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
NCN. V. Chumovatov
N. V. Chumovatov
NCN. A. Chernyh
N. A. Chernyh
GSG. M. Saharova
G. M. Saharova
NAN. S. Antonov
N. S. Antonov
VRV. V. Romanov
V. V. Romanov
AEA. E. Ergeshov
A. E. Ergeshov
Introduction. At the end of 2020, the clinical cure rate in all registration groups of patients with pulmonary tuberculosis was 48.2 %. There is now ample evidence that additional risk factors influence the more severe course of pulmonary tuberculosis and reduce the effectiveness of standard anti-tuberculosis therapeutic programs. Diabetes mellitus and tobacco use are among the significant risk factors. Complementing standard TB therapeutic programs with nicotine addiction and diabetes mellitus treatment programs with the formation of an individual comprehensive patient treatment plan will increase the effectiveness of TB treatment. Thus, the goal of this work is to demonstrate the high effectiveness of an individualized approach to the treatment of a patient with pulmonary tuberculosis with a comorbid background.The aim of the work was to demonstrate the high effectiveness of an individualized approach to the treatment of a patient with pulmonary tuberculosis with a comorbid background.Materials and methods At the Central TB Research Institute the patient underwent a comprehensive examination, including mandatory, additional and facultative methods of investigation. Based on the findings, the patient underwent complex treatment: antituberculosis chemotherapy, correction of carbohydrate metabolism disorders using oral antidiabetic drugs, nicotine replacement therapy according to the selected scheme, taking into account the degree of nicotine addiction.Results and Discussion Against the background of complex treatment, by four months of therapy the following was achieved: knockdown of systemic inflammatory reactions, cessation of bacterial excretion, compensation of diabetes mellitus. X-ray examination revealed closure of a large decay cavity, resorption and consolidation of focal infiltrative changes. There was regression of infiltrative changes of trachea and bronchi. The patient completely stopped using tobacco due to nicotine replacement therapy.Conclusion This clinical example demonstrates the high effectiveness of an individualized approach to the treatment of tuberculosis, including the need for an individualized regimen of anti-tuberculosis therapy, adequate compensation for diabetes mellitus, and the implementation of relevant smoking cessation techniques among smokers with pulmonary tuberculosis.

12 December 2022 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
NCN. V. Chumovatov
N. V. Chumovatov
NAN. S. Antonov
N. S. Antonov
GSG. M. Sakharova
G. M. Sakharova
NCN. A. Chernyh
N. A. Chernyh
VRV. V. Romanov
V. V. Romanov
LRL. I. Rusakova
L. I. Rusakova
According to the WHO, tobacco use is currently the leading cause (16%) of all adult deaths. Studies conducted in many countries and in the Russian Federation have revealed the association between smoking and pulmonary tuberculosis (PT). Due to the negative impact of tobacco smoking on the course of tuberculosis and the effectiveness of treatment, there is a need to develop approaches to smoking cessation in patients with PT. Aim. To evaluate the effectiveness of the treatment of PT in smoking patients in combination with nicotine replacement therapy in an inpatient setting. Methods. The study included 27 patients with a confirmed diagnosis of PT. The inclusion criteria for the study were: age 18 years and older, patients who are currently active smokers, and a confirmed diagnosis of PT. The exclusion criteria were the presence of asthma and oncological diseases, unconfirmed diagnosis of PT, and earlier history of tobacco use. In the study group, an analysis of the smoking status was carried out. This status was based on the length of smoking period, number of cigarettes per day, and calculation of the smoking patient index. The degree of nicotine addiction, the presence of withdrawal symptoms, and the motivation of patients to quit smoking were assessed. The principle of nicotine dependence treatment was to prescribe nicotine-containing drugs in a dose depending on the degree of nicotine addiction. The duration of treatment was 12 weeks. Results. After 4 months of PT treatment, the cessation of bacterial excretion was detected 2 times more often, the closure of decay cavities in the lung tissue - 2.5 times more often, the relief of systemic inflammatory reactions - 2 times more often in patients who quit smoking than in patients who continue to smoke. Conclusion. This study showed that the treatment of PT in smokers was more effective in combination with nicotine replacement therapy for smoking cessation than when the patients continued to smoke.

12 July 2024 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
NCN. V. Chumovatov
N. V. Chumovatov
OKO. G. Komissarova
O. G. Komissarova
NCN. A. Chernyh
N. A. Chernyh
VRV. V. Romanov
V. V. Romanov
Currently, according to the World Health Organization, the targets for the effectiveness of treatment of patients with pulmonary tuberculosis do not achieve their goals. In this regard, it is urgent to search for optimal integrated approaches in the treatment of patients with pulmonary tuberculosis.The aim of the work is to demonstrate the high effectiveness of the use of methods of collapse therapy and CBB in the complex treatment of a patient with a widespread tuberculosis process.Materials and methods. The analysis of the patient’s medical documentation was carried out, the data of the anamnesis of the disease, the analysis of the X-ray archive, the data of clinical, laboratory and instrumental examinations were studied.Results. Multidrug resistance (MDR) of Mycobacterium tuberculosis (MBT) was established on the 1st day of hospitalization. Comprehensive treatment was carried out in full: chemotherapy according to the MDR-tuberculosis regimen, pneumoperitoneum for 8 months, CBB for 6 months.Discussion. The presented clinical example demonstrates that against the background of a significant decrease in immunity due to the severe course of viral pneumonia, previously undetected pulmonary tuberculosis has taken a progressive course. Due to the use of complex treatment in a patient with a widespread tuberculosis process, clinical improvement was achieved, the closure of massive decay cavities in lung tissue and resorption of focal infiltrative changes was radiologically achieved.Conclusion. A clinical example demonstrates the high effectiveness and safety of the use of collapse therapy methods in the complex treatment.

19 March 2025 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
NCN.V. Chumovatov
N.V. Chumovatov
NCN.A. Chernyh
N.A. Chernyh
OKO.G. Komissarova
O.G. Komissarova
VRV.V. Romanov
V.V. Romanov
Pulmonary tuberculosis and malignant neoplasms (MNs) are important global healthcare issues. There has been a large number of studies on the relationship between pulmonary tuberculosis and MNs, but comprehensive approaches to diagnosis and treatment of these diseases need to be developed and implemented. Objective. To study the relationship between pulmonary tuberculosis and malignant neoplasms at the current stage of phthisiology. Materials and methods. Analysis of domestic and foreign databases for the period from 1976 to 2024 was performed. The following keywords were used for the search of literature: «tuberculosis», «cancer», «malignant neoplasms». Results. There is a large amount of publications in the world literature proving that the mechanisms of development of the tuberculous inflammation and the neoplastic process, in particular the formation of immune response, are similar, and this makes it difficult to timely detect and identify the pathological process. The cause-effect relationship of these diseases has been proven. As a result of this correlation, the tuberculous process increases the risk of MNs development by 3 times or more, and conversely, the development of the neoplastic process can lead to the risk of tuberculous infection accession or reactivation of «old» post-tuberculous changes. Tuberculosis and MNs have similar clinical symptoms, which complicates timely diagnosis and leads to establishment of misdiagnosis. Similarity of these two diseases is also found in X-ray examination. In this connection, the important direction at the current stage of phthisiology is to find comprehensive approaches to diagnosis, management and treatment of patients with tuberculosis and lung cancer. Conclusion. The results of the literature review showed a close relationship between the tuberculous process and malignant lung neoplasms. In immune disorders, a favorable environment for the development of both tuberculosis and neoplastic process is formed. Tuberculosis and malignant neoplasms have similar clinical and radiological symptoms, which complicates timely diagnosis and may lead to the establishment of misdiagnosis.

12 December 2024 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
NCN. V. Chumovatov
N. V. Chumovatov
NCN. A. Chernyh
N. A. Chernyh
OKO. G. Komissarova
O. G. Komissarova
VRV. V. Romanov
V. V. Romanov
An important area in the work of the TB service is the search for integrated approaches in the treatment of patients with pulmonary tuberculosis. One of these approaches is the widespread use of methods of artificial pneumoperitoneum and endobronchial valvular bronchoblocation. The active use of surgical treatment can also be an effective technique.The aim of the work is to study the effectiveness of the use of methods of artificial pneumoperitoneum and endobronchial valvular bronchoblocation as preoperative preparation in patients with pulmonary tuberculosis.Materials and methods. The study included 295 patients: group 1 — patients treated with artificial pneumoperitoneum and endobronchial valvular bronchoblocation (n = 201); group 2 consisted patients who did not use these methods (n = 94).Results. Operations with the smallest volume were significantly more often performed in patients of group 1a (34.8 %), compared with group 1b and group 2a (p1a–1b = 0.016, p1a–2a = 0.014). Large-volume surgery was significantly more often performed in patients of group 2 (41.1 %, p1a–2a = 0.028).Discussion. The use of artificial pneumoperitoneum and endobronchial valvular bronchoblocation helps to reduce the volume of surgical intervention. Thus, in the group of patients after effective endobronchial valvular bronchoblocation and artificial pneumoperitoneum, lung resection within 1–2 segments was significantly more often used; whereas in the group of patients who did not use artificial pneumoperitoneum and endobronchial valvular bronchoblocation techniques, large-scale surgical interventions were more often resorted to.Conclusion. The use of artificial pneumoperitoneum and endobronchial valvular bronchoblocation helps to increase the effectiveness of treatment and reduce the volume of surgery, preventing significant damage to the loss of lung tissue.

1 December 2025 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
NCN.V. Chumovatov
N.V. Chumovatov
GSG.M. Sakharova
G.M. Sakharova
NAN.S. Antonov
N.S. Antonov
OKO.G. Komissarova
O.G. Komissarova
NCN.A. Chernyh
N.A. Chernyh
VRV.V. Romanov
V.V. Romanov
The pulmonary tuberculosis sequelae are currently an urgent problem in global health. Outcomes of pulmonary tuberculosis include structural, functional, and infectious changes. Objective. To study the prevalence of the tuberculosis sequelae, as well as risk factors and clinical manifestations of active pulmonary tuberculosis that affect the development of the sequelae in TB patients who have completed treatment. Materials and methods. Russian and foreign databases eLibrary.ru, PubMed, and MedLine were searched for the period from 1992 to 2024 using the following keywords: «tuberculosis», «post-tuberculosis changes», «smoking», «risk factors», «bronchopulmonary diseases», «tuberculosis», «post-tuberculosis changes», «pulmonary health», and «functional lung disorders». Results. Post-tuberculosis disorders of the bronchopulmonary system caused by active tuberculosis can play a key role in impairing the pulmonary health of patients after the treatment. A wide range of tuberculosis clinical forms can cause post-tuberculosis changes, including infiltrative, disseminated, fibro-cavernous, and cirrhotic forms. The manifestations of active tuberculosis, causing post-tuberculosis changes, are very diverse and, according to various studies, occur in at least 40% of patients who recovered from tuberculosis within 5 years. Airflow restriction caused, among other things, by bronchial obstructive disorders is the most common tuberculosis sequela. Its prevalence is up to 30% in various populations and is associated with a decrease in lung ventilation. Conclusion. A high prevalence of pulmonary tuberculosis sequelae was found. The clinical manifestations of post-tuberculosis changes are very diverse and include persistent respiratory symptoms, impaired lung ventilation (broncho-obstructive and restrictive disorders), the development of bronchiectasis, and bronchial stenosis. Therefore, developing comprehensive approaches to reduce the risk of post-tuberculosis sequelae, along with programs for their prevention and treatment, is a relevant direction in pulmonary health prevention.